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Abstract
Background: Little information exists on the clinical characteristics and factors related to
hospital mortality in patients with active infective endocarditis referred for surgery.
Methods: Between January 1, 2003 and December 31, 2006, 86 patients (56 males, 30 fe-
males, mean age 59.2 years) with active infective endocarditis were referred to our Department
(2.8% of overall hospitalizations). The relation of several clinical, laboratory and echocardio-
graphic findings at admission with hospital mortality was evaluated.
Results: A native valve (NVE) was involved in 50/86; the other 30 had a prosthetic valve
endocarditis (PVE). Six had pacemaker endocarditis. The aortic valve was involved more
frequently than the mitral valve, both in NVE and PVE. The tricuspid valve was involved in
four drug addicts; 51% of patients were in NYHA class III–IV. Staphylococci and streptococci
were isolated in 69% of patients (39% vs 30%). Blood cultures were negative in 24%. Overall
hospital mortality has been 11.6%. Two patients died before surgery, eight in the perioperative
period. Hospital mortality was closely related to age, clinical and laboratory evidence of ad-
vanced septic condition (temperature > 38°C, leukocytosis and creatinine > 2.0 mg/dL) and
hemodynamic impairment.
Conclusions: Active infective endocarditis is a significant cause of referral to heart surgery
departments and hospital mortality is still > 10%. Clinical and laboratory parameters easily
available at admission suggest that severe sepsis and/or hemodynamic impairment may be
helpful in predicting the clinical outcome in this group of high risk patients. (Cardiol J 2010; 17,
6: 566–573)
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Introduction
Despite a better knowledge of predisposing
factors [1–3], the availability of new antibiotics [4],
and closer adherence to prophylaxis guidelines, in-
fective endocarditis remains a not uncommon se-
vere clinical condition which is associated with high
hospital mortality [5]. Symptoms may be over-
looked in the early phases of disease. A long time
between the early clinical manifestations and defi-
nite diagnosis may allow severe valvular damage
and hemodynamic impairment to occur and short-
en long term survival [6]. Medical treatment alone
is frequently ineffective in these patients and three
month mortality usually exceeds 30% [7]. Surgery,
even in the active phase of disease, has been shown
to significantly improve prognosis [8]. The recent
International Endocarditis-Prospective Cohort
Study reported that surgery was associated with
a 39% decrease in the risk of death in comparison
to medical treatment [9]. IE patients referred for
surgery are high risk patients. Hospital outcome is
related to severity of hemodynamic impairment
and/or septic condition [10]. The aim of our prospec-
tive study was to assess the clinical and echocar-
dographic characteristics of patients with active
infective endocarditis referred to a tertiary heart
surgery center, and to investigate whether simple
clinical, laboratory and echo criteria, readily avail-
able at hospital admission, could predict clinical
outcome in this high risk group.
Methods
Study design
We included in our study 86 consecutive pa-
tients admitted between January 1, 2003 and Decem-
ber 31, 2006 for active infective endocarditis (IE) to
the Heart Surgery Department of AOU Careggi,
Florence, Italy, a tertiary heart surgery referral
center  serving a population > 1.5 million.
Informed consent was obtained from each pa-
tient and the study protocol conforms to the ethi-
cal guidelines of the 1975 Declaration of Helsinki
as reflected in a priori approval by the institution’s
human research committee.
On admission to our department, patients un-
derwent: accurate history collection, physical ex-
amination with particular attention to heart (func-
tional capacity assessed according to NYHA classi-
fication), neurological findings, skin or ocular
manifestations , history or clinical evidence of sys-
temic embolism, assessment of vital signs, mea-
surement of body temperature, electrocardiogram,
and laboratory examinations (hemoglobin concen-
tration, leukocyte count, serum creatinine). At least
three samples for blood cultures were collected
within 12 hours. Blood samples were initially pro-
cessed by an automatic system (Bactec, BD) and
incubated for five days. When, following incubation,
a bottle became positive, it was processed on cho-
colate AGAR, blood AGAR and orientation AGAR.
MIC was calculated for different antibiotics in rela-
tion to isolated micro organism. Transthoracic and
transesophageal echocardiography were performed
with a Sequoia Accuson instrument (Siemens Medi-
cal Solution, Mount View, California, USA). All ex-
aminations were performed by two senior echocar-
diographers adhering to American Society of
Echocardiography (ASE) guidelines [11]. A diagno-
sis of endocarditis was made in patients with syste-
mic symptoms of infective disease who fulfilled the
major echocardiographic criteria for IE which was
thereafter confirmed by surgery [12].
Particular care was taken to research the pre-
sence and location of vegetations and/or perivalvu-
lar spreading of the infective process (abscesses,
fistulas etc.). Standard semi-quantitative method
was used to assess the severity of regurgitation:
absent, mild (< 2+) or moderate-severe (3+ – 4+).
Left ventricular ejection fraction (LVEF) was eva-
luated using the area-length method.
Indications for surgery
Hemodynamic impairment associated with severe
mitral or aortic valve regurgitation was the main
indication for surgery in 48% of patients. In 15 pa-
tients, surgery was indicated for paravalvular spread-
ing of the infection with abscesses (14 subjects, 92%
in prosthetic valve endocarditis) in one patient for aor-
tic to right atrium fistula. Large vegetations > 10 mm
diameter (24%) and recurrent embolism were the oth-
er main indications for surgery. All patients under-
went surgery within seven days after starting ma-
ximal antibiotic treatment, unless impairment of
clinical conditions suggested an earlier solution.
Statistical analysis
The quantitative variables are shown as means
and standard deviations. In case of not continuous
parameters has been reported the frequency of dis-
tribution. The statistical analysis of clinical data was
performed using Student’s t test for continuous
data, while for categorical variables the c2 test was
employed. Statistical analysis of echocardiograph-
ic parameters was carried out by ANOVA test.
A probability value < 0.05 was considered statisti-
cally significant.
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Results
General characteristics of patients
In the period under investigation, 86 patients
with definite diagnosis of active IE [7] were admit-
ted to our Division (2.8% of overall hospital admis-
sions); 63 patients (73%) were referred from pri-
mary and secondary hospitals, while the other 27%
were admitted through the Emergency Department
of our hospital.
The mean age of patients was 59.5 years (range
22–84). There were more men than women (56 to
30) but the women were significantly older (63.1 vs
57.5 years; p = 0.03; Table 1). Native valves were
involved in 50 patients (native valve endocarditis
— NVE), while in 30, prosthetic valves were affect-
ed (prosthetic valve endocarditis — PVE). Twelve
had early PVE (onset of clinical manifestations with-
in 12 months from previous valvular heart surgery),
while in the other 18 cases, the time elapsed from
previous surgery and the onset of symptoms aver-
aged 8.5 years (late PVE). The remaining six pa-
tients had pacemaker endocarditis.
Clinical features and laboratory findings
The duration between the onset of symptoms
and hospitalization had been < 30 days in 33 pa-
tients (38%), and between one and six months in
another 38 of them. In the remaining 15 subjects,
symptoms had lasted > six months before a defi-
nite diagnosis. At hospital admission, 51% of pa-
tients were in NYHA functional class III or IV (Ta-
ble 1). Fifty-five patients had fever (64%). A body
temperature > 38°C was found in 18 patients (17%).
Anemia (defined as serum hemoglobin concentra-
tion < 12 g/dL) was observed in 62 patients. In
31 patients, hemoglobin concentration was lower
than 10 g/dL. White blood cell count > 10,000/mm3
was present in 30 patients; only nine showed values
> 15.000/mm3.
Renal function was significantly impaired (se-
rum creatinine > 2 mg/dL) in nine patients, while
in 11 patients serum creatinine ranged between
1.5 and 2 mg/dL. Clinical manifestations and/or in-
strumental evidence of peripheral embolism were
detected in 38% of patients, while petechiae and he-
maturia were present in five and three subjects
respectively. C-reactive protein (CRP) values are
reported in Table 1.
Average heart rate, systolic and diastolic blood
pressure are reported in Table 1. Only four patients
had systolic pressure below 100 mm Hg. A heart
rate above 100 beats per minute was recorded in
29% of subjects.
Organisms responsible
for infective endocarditis
Blood cultures were positive in 63 of the 86 pa-
tients (73%). Staphylococci were the most frequent
isolated micro organism (Table 2). Methicillin-resis-
tant staphylococci were isolated in eight patients.
Streptococci were isolated in 41% of subjects with
positive blood cultures, while Gram-negative in five.
Fungal endocarditis (candida parapsilosis) was found
in one immunodeficient patient. We detail in Table 2
the different pathogens responsible for IE respec-
tively in NVE, PVE and pacemaker endocarditis.
Blood cultures were negative in 23 patients.
Almost all these patients had been referred from
peripheral hospitals and already treated with em-
piric large spectrum antibiotic therapy. ‘Culture
negative’ endocarditis was more frequently ob-
served (15 out of 23) in patients with NVE.
Echocardiographic findings
Preserved left ventricular systolic function
(LVEF > 50%) was found in 70% of patients. Left
ventricular function was moderately depressed
(LVEF between 35 and 50%) in 27%. Only three
patients showed a severe functional impairment
(LVEF < 30%).
Table 1. Characteristics of patients included in
the study.
Patients (mean age ± SD)
Overall (n = 86) 59.5±16.1
Men (n = 56) 57.3±15.8
Women (n = 30) 63.1±16.8
Systolic blood pressure [mm Hg] 127±23
Diastolic blood pressure [mm Hg] 68±14
Heart rate [beats/min] 112±9.5
Type of valve involvment:
Native valve endocarditis 50
Prosthetic valve endocarditis 30
Pacemaker endocarditis 6
Valve involved:
Mitral 28
Aortic 38
Tricuspid 4
Mitral + aortic 10
NYHA class
IV 21
III 23
II 14
I 28
C-reactive protein [mg/L] 23.7±6.6
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Native valve endocarditis. Endocarditic pro-
cess involved a single valve in 40 subjects (mitral
valve 17, aortic valve 19, tricuspid valve 4). In the
remaining ten patients, both aortic and mitral valve
were affected by the infective process. In Table 3,
echocardiographic findings are reported in detail.
Moderate to severe mitral regurgitation was found
in nine patients with isolated aortic endocarditis,
suggesting severe hemodynamic impairment lead-
ing to mitral annular dilation. About 50% of patients
had severe tricuspid regurgitation with pulmonary
hypertension. Single or multiple valve vegetations
(average diameter 9.2 mm, range 3 to 20 mm) were
detected in 47 patients. In two patients, perforation
of a cusp was the cause of severe aortic regurgita-
tion. Only one case of aortic NVE was complicated
by paravalvular abscess and required homograft
replacement. A severe left ventricular (LV) dys-
function (LVEF < 35%) was found in only two pa-
tients, while in 13 LVEF was between 35 and 50%.
Prosthetic valve endocarditis (Table 4)
Prosthetic valvular infection involved aortic
valve in 19 patients and mitral valve in 11. In both
positions, the infective process more frequently
involved biological than mechanical valves. Howev-
er, this may relate only to the larger number of bio-
logical valves implanted in comparison to mechani-
cal prostheses. Vegetations were detected in four
patients with aortic biological prosthetic endocardi-
tis, while a perivalvular abscess was detected in 12.
In 13 out of 19 patients with aortic PVE we found
moderate to severe aortic valvular regurgitation:
a perivalvular leak was responsible for regurgita-
Table 2. Causal organism in relation to type of infected valve or device.
Etiological agent Native valves Prosthetic valves PM endocarditis Total
Staphylococcus aureus 9 (18%) 7 (23%) 1 (17%) 17 (23%)
Staphyloccoccus epidermidis 3 (6%) 5 (17%) 3 (50%) 11 (13%)
Other staphylococci 2 (4%) 0 (0%) 1 (17%) 3 (4%)
Streptococcus faecalis 2 (4%) 5 (17%) 0 (0%) 7 (7%)
Streptococcus viridans 4 (8%) 0 (0%) 0 (0%) 4 (4%)
Other streptococci 12 (24%) 3 (10%) 0 (0%) 15 (18%)
Gram-negative 2 (4%) 3 (10%) 0 (0%) 5 (7%)
Candida 1 (2%) 0 (0%) 0 (0%) 1 (1%)
Negative blood culture 15 (30%) 7 (23%) 1 (17%) 23 (27%)
PM — pacemaker
Table 3. Echocardiographic findings in native
valve endocarditis.
Endocarditic Aortic Mitral Tricus-
process pidal
Mitral regurgitation
Mild (£ 2+) 12 5 1
Moderate-severe 9 22 1
(3+/4+)
Absent 8 0 2
Aortic regurgitation
Mild (£ 2+) 2 3 0
Moderate-severe 23 11 0
(3+/4+)
Absent 4 13 4
Tricuspidal regurgitation
Absent-mild 13 13 2
Moderate-severe 16 14 2
Table 4. Echocardiographic findings in prosthetic
valve endocarditis.
Endocarditic Aortic Mitral Tricus-
process pidal
Mitral regurgitation
Mild (£ 2+) 10 3 0
Moderate-severe 6 3 0
(3+/4+)
Absent 3 5 0
Aortic regurgitation
Mild (£ 2+) 4 8 0
Moderate-severe 13 0 0
(3+/4+)
Absent 2 3 0
Tricuspidal regurgitation
Evident 8 10 0
Absent 11 1 0
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tion in six patients, while in the other seven valve
regurgitation was related to damage and perforation
of prosthetic valve leaflets. Mitral valve regurgitation
was found in 22 patients. Left ventricular function was
moderately depressed (LVEF 35–50%) in 30% of
cases of PVE.
Pacemaker endocarditis
All six patients with pacemaker IE developed
vegetations on ventricular and/or atrial electrodes.
Five patients (83%) had a significant tricuspid re-
gurgitation.
Hospital outcome
Mortality. Overall hospital mortality has been
11.6% (10 out of 86); mortality rose to 12.5% (10
out of 80) when patients with pacemaker endocardi-
tis were excluded from the analysis. Two patients
died before surgery and eight in the post-operative
period. In one case, death occurred during surgery
for rupture of atrioventricular sulcum. The other
patients died within 30 days from intervention:
three due to irreversible cardiogenic shock, three
due to multiple systemic organ failure as a result of
severe septic shock, and the last one for rupture of
splenic artery mycotic aneurysm.
Clinical factors related to mortality. Age
was related to higher hospital mortality. Patients
who died were on average 11 years older than pa-
tients discharged alive (Table 5). Gender did not
influence clinical outcome. We did not find any sig-
nificant relation between survival and systolic and
diastolic arterial blood pressure at admission,
while a higher heart rate was related to an in-
creased risk of death. Patients with evidence of LV
dysfunction had a higher risk of death (nine of the
ten patients who died had LVEF < 50%,  compared
to 30 out of 56 of those who survived; p < 0,0001;
Table 6). Survival did not show any significant re-
lation with the affected valve and was not related
to native or prosthetic valve involvement. We
failed to find any prognostic value of the degree of
mitral or aortic regurgitation in both NVE and PVE
or of the presence of complicated endocarditis
(paravalvular abscesses or aortic — right atrium
fistula).
Clinical and laboratory parameters related to
severity of septic condition (such as higher tempera-
Table 5. Clinical outcome in relation to demographic and hemodynamic factors.
Parameter Patients discharged alive Patients died t p
(n = 76) (n = 10)
Age [years] 58.1 ± 16.3 69.7 ± 10 2.194 0.03
Heart rate [bpm] 87 ± 19 105 ± 20 2.67 0.009
Systolic heart pressure [mm Hg] 127 ± 22 130 ± 23 0.384 0.710
Diastolic heart  pressure [mm Hg] 67 ± 16 71 ± 16 0.69 0.492
Table 6. Clinical outcome in relation to echocardiographic parameters.
Parameter Patients discharged alive Patients died c2 p
(n = 76) (n = 10)
Left ventricular ejection fraction
> 50% 56 1
35–50% 18 5 25.7 < 0.0001
< 35% 2 4
Aortic regurgitation
3+ – 4+ 36 2
< 2+ 30 5 1.93 0.37
0 20 3
Mitral regurgitation
3+ – 4+ 32 3
< 2+ 26 4 0.57 0.77
0 18 3
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ture, leukocytosis and impaired renal function but
not CRP) were significantly related to mortality
(Table 7). There was no definite statistical relation
between micro organisms isolated in blood cultures
and in hospital outcome (Table 8).
Discussion
Infective endocarditis remains in the 21st cen-
tury a not uncommon cause of hospitalization with
a relevant mortality rate [5, 13].
Table 7. Clinical outcome in relation to different clinical and laboratory parameters.
Parameter Patients discharged alive Patients died c2 p
(n = 76) (n = 10)
Temperature
> 38°C 17 4
37–38°C 34 6 2.51 0.01
< 37°C 25 0
Total WBC
> 15,000/mm3 8 5
10,000–15,000/mm3 18 4 22.8 0.001
< 10,000/mm3 50 1
Hemoglobin
< 10 g/dL 24 6
10–12 g/dL 24 3 3.9 0.13
< 12 g/dL 28 1
Creatinine
> 2 mg/dL 9 1
1.5–2 mg/dL 7 5 12.36 0.002
< 1.5 mg/dL 60 4
C-reactive protein
> 15 mg/L 26 3
0.8 0.65
< 15 mg/L 50 7
Table 8. Relation of type and site of valve affected, NYHA functional status and causal micro-organism
to clinical outcome.
Parameter Patients discharged alive Patients died c2 p
(n = 76) (n = 10)
Native valve IE 44 4
1.97 0.32
Prosthetic valve IE 32 6
Valve affected
Mitral 33 4
Aortic 34 6 0.7 0.59
Tricuspid 5 0
NYHA class
IV 16 5
III 22 1
4.51 0.21
II 13 1
I 25 3
Etiology
Staphylococci 27 4
Streptococci and Gram-negative 39* 3 0.6 0.6
Negative blood cultures 20 3
*Including 1 case of fungal IE; IE — infective endocarditis
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Our study evaluated a selected group of sub-
jects suffering from severe active clinical disease
who had been referred to a tertiary heart surgery
center for surgical treatment.
The average age of patients was 59.5 ± 16 ye-
ars, similar to that reported recently by the In-
ternational Collaboration on Endocarditis-Prospec-
tive Cohort Study [9]. Although NVE is significantly
more frequent than PVE [3], the relatively higher
percentage of PVE reported in our study accords
with investigations from surgical centers, since
medical treatment is rarely effective in PVE [14,
15]. Intravenous drug use is a high risk condition
for IE. However, less than 5% of our patients were
drug addicts. Since antibiotic treatment is often ef-
fective in these patients, a low referral for surgery
may explain this finding.
Staphylococci were the more frequent etiologi-
cal agents, again agreeing with previous investiga-
tions [16, 17]. Due to the limited number of events
we were not able to demonstrate a statistical rela-
tionship between etiological agent and prognosis.
However, of the ten patients who died during hospi-
talization, four had positive blood cultures for staphy-
lococcus aureus, while a staphylococcus aureus in-
fection was found only in 17% of surviving patients.
Diagnosis of culture negative endocarditis was
made in 24% of patients, a percentage similar to
other surgical series [3–9]. Culture negative en-
docarditis in our study was more frequent in pa-
tients with NVE mainly referred from peripheral
hospitals, where a large spectrum empiric antibiotic
therapy had been administered before definite dia-
gnosis. Since all patients had echocardiographic and,
more relevantly, surgical, demonstrations of en-
docarditis, our data supports the hypothesis that
inappropriate antibiotic treatment is the main fac-
tor responsible for negative blood cultures [18, 19].
Netzer et al. [3] reported 15% hospital mortal-
ity in patients with IE. Similar results were report-
ed in other investigations [13]. Overall hospital mor-
tality has been 17.7% in the International Collabo-
ration on Endocarditis-Prospective Cohort Study
[9]. In the present study, overall hospital mortality
has been 11.6% (and 12.5% when patients with
pacemaker endocarditis were excluded from the
analysis) with a higher survival rate compared to
that previously reported from medical institutions
[3]. Several demographic and clinical factors have
been associated with adverse outcome in patients
with active IE [3, 10]. Heterogeneity of examined
populations, long enrolment periods often lasting
more than ten years, and a prevalence of studies
from ‘medical’ institutions may be responsible for
the wide difference between hospital and long term
mortality reported in literature. Advanced age, se-
verity of hemodynamic impairment and of septic
state are significantly related to clinical outcome in
the patients included in our study.
The anatomical site of the infectious process and
its diffusion to paravalvular tissues, the involvement
of a native or prosthetic valve, and the degree of valve
regurgitation, did not affect short-term outcome.
Hospital mortality was significantly higher in
patients with PVE in comparison to NVE in stud-
ies from medical institutions [3, 20, 21]. The use-
fulness of surgical treatment in patients with PVE
is supported by the results of the present investi-
gation in which hospital survival rates did not dif-
fer between PVE and NVE.
Higher mortality was found in patients with
lower LVEF. Survival, at variance with previous
investigations [3, 9, 10], was not related to function-
al impairment expressed as NYHA class at admis-
sion. Surgical treatment in patients with severe
acute hemodynamic overload may prevent the de-
velopment of irreversible evolution leading to car-
diogenic shock and contribute to lower in-hospital
mortality. In patients with active IE, evidence of LV
dysfunction may more accurately predict an adverse
outcome than clinical evaluation of functional status.
Age is associated with increased mortality,
mainly due to the high prevalence of severe co-
morbidities. Parameters easily measurable at hos-
pital admission may help to identify a group of pa-
tients at higher risk of death. Fever, elevated WBC
(> 15,000 mm3) and serum creatinine levels above
1.5 mg/dL at hospital admission were significantly
associated with an increased risk of hospital mor-
tality. Patients who died had a heart rate significant-
ly higher in comparison to patients discharged alive.
Similar results were reported in the study by Wal-
lace et al. [10]. The relation between an impaired
renal function and a poor prognosis in IE has been
reported by other authors [3, 22]. Different patho-
physiological factors have been hypothesized (he-
modynamic changes, immune complex glomerular
damage, antibiotic toxicity) [23, 24]. Results from
the present investigation suggest that even small
changes in renal function have negative prognostic
values, and these may be related to the severity of
septic process and of consequent intrarenal func-
tional hemodynamic changes. The different clinical
and laboratory data suggesting a severe septic con-
dition (fever, elevated WBC, elevated CRP and de-
creased albumin concentration) with a poor prog-
nosis reported in the study by Wallace et al. [10] is
in agreement with this hypothesis.
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Limitations of the study
Patients included in this study were referred
to a single tertiary heart surgery center and there-
fore are not representative of the overall IE popu-
lation. Few investigations however have evaluated
the clinical characteristics of patients with active IE
referred for surgical treatment and their relation  to
hospital mortality. An easy clinical and instrumen-
tal approach may allow the identification of high risk
patients. Future investigations are needed to eva-
luate if more sensitive markers may improve the
capability to detect high risk patients, in whom
a more aggressive surgical approach may contri-
bute to a reduction in mortality.
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